Alimentary Pharmacology & Therapeutics

Review article: the treatment of non-alcoholic steatohepatitis with thiazolidinediones
pp. 897-905(9)
Authors: REYNAERT, H.; GEERTS, A.; HENRION, J.

Review article: how and when to use ciclosporin in ulcerative colitis
pp. 907-916(10)
Authors: DURAI, D.; HAWTHORNE, A. B.

Systematic review: acute colonic pseudo-obstruction
pp. 917-925(9)
Authors: SAUNDERS, M. D.; KIMMEY, M. B.

Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study
pp. 927-934(8)
Authors: LU, W. Z.; GWEE, K. A.; MOOCHHALLA, S.; HO, K. Y.

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey
pp. 935-942(8)
Authors: ANDREWS, E. B.; EATON, S. C.; HOLLIS, K. A.; HOPKINS, J. S.; AMEEN, V.; HAMM, L. R.; COOK, S. F.; TENNIS, P.; MANGEL, A. W.

Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin
pp. 943-949(7)
Authors: GUIDI, M.; MURATORI, P.; GRANITO, A.; MURATORI, L.; PAPPAS, G.; LENZI, M.; BIANCHI, F. B.

Anti-cyclic citrullinated peptide antibodies in type 1 autoimmune hepatitis
pp. 951-955(5)
Authors: FUSCONI, M.; VANNINI, A.; DALL'AGLIO, A. C.; PAPPAS, G.; CASSANI, F.; BALLARDINI, G.; FRISONI, M.; GRASSI, A.; BIANCHI, F. B.; ZAULI, D.

Capsule endoscopy – comparison of two strategies of bowel preparation
pp. 957-962(6)
Authors: NIV, Y.; NIV, G.; WISER, K.; DEMARCO, D. C.

Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome
pp. 963-969(7)
Authors: PENNING, C.; VECHT, J.; MASCLEE, A. A. M.

Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
pp. 971-979(9)
Authors: SCHILLER, C.; FRÖHLICH, C.-P.; GIESSMANN, T.; SIEGMUND, W.; MÖNNIKES, H.; HOSTEN, N.; WEITSCHIES, W.

Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome
pp. 981-988(8)
Authors: LEE, K. J.; KIM, J. H.; CHO, S. W.

Low rectal volumes in patients suffering from fecal incontinence: what does it mean?
pp. 989-996(8)
Authors: SIPROUDHIS, L.; EL ABKARI, M.; EL ALAOUI, M.; JUGUET, F.; BRETAGNE, J. F.

Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment
pp. 997-1003(7)
Authors: CADEDDU, F.; BENTIVOGLIO, A. R.; BRANDARA, F.; MARNIGA, G.; BRISINDA, G.; MARIA, G.

The association of body mass index with Barrett's oesophagus
pp. 1005-1010(6)
Authors: STEIN, D. J.; EL-SERAG, H. B.; KUCZYNSKI, J.; KRAMER, J. R.; SAMPLINER, R. E.

Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian–French cohort of healthy subjects
pp. 1011-1021(11)
Authors: ZERBIB, F.; BRULEY DES VARANNES, S.; ROMAN, S.; POUDEROUX, P.; ARTIGUE, F.; CHAPUT, U.; MION, F.; CAILLOL, F.; VERIN, E.; BOMMELAER, G.; DUCROTTÉ, P.; GALMICHE, J.-P.; SIFRIM, D.

Risk factors for non-cardiac chest pain in the community
pp. 1023-1031(9)
Authors: WISE, J. L.; LOCKE, G. R.; ZINSMEISTER, A. R.; TALLEY, N. J.

Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection
pp. 1033-1040(8)
Authors: SUGIMOTO, M.; FURUTA, T.; SHIRAI, N.; NAKAMURA, A.; KAJIMURA, M.; SUGIMURA, H.; HISHIDA, A.; ISHIZAKI, T.

Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin
pp. 1041-1046(6)
Authors: GISBERT, J. P.; GISBERT, J. L.; MARCOS, S.; OLIVARES, D.; PAJARES, J. M.